Following the receipt of customer reports, Hospira Healthcare Corporation, in consultation with Health Canada, is informing Healthcare professionals that some vials of Dacarbazine for Injection 600 mg/vial, BP may turn pink immediately after reconstitution or during storage of reconstituted product. Dacarbazine for Injection is indicated as palliative therapy for metastatic malignant melanoma. Read more
here.
No comments:
Post a Comment